Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: A prospective cohort study

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 10, 2013, Pages 1248-1254

  Linton, M S ^a   Kroeker, K ^a   Fedorak, D ^a   Dieleman, L ^a   Fedorak, R N ^a  

^a Division of Gastroenterology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MESALAZINE; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; VIRUS CAPSID ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SEROPREVALENCE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIGENS, VIRAL; AZATHIOPRINE; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885955536     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12503     Document Type: Article

References (17)

1. Posthuma ER, Westendrop RG, van der Sluys Veer A, et al,. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 1995; 36: 311-3.
2. N'Guyen Y, Andreoletti L, Patey M, et al,. Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease. J Clin Microbiol 2009; 47: 1252-4.
3. Garrido Serrano A, Perez Martin F, Guerrero Igea FJ, et al,. Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease. Gastroenterol Hepatol 2000; 23: 7-8.
4. Schubert S, Renner C, Hammer M, et al,. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. J Heart Lung Transplant 2008; 27: 100-5.
5. Biank VF, Sheth MK, Talano J, et al,. Association of crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. J Pediatr 2011; 159: 808-12.
6. Francolla KA, Altman A, Sylvester FA,. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab. J Pediatr Gastroenterol Nutr 2008; 47: 193-5.
7. Babu L, Boctor D, Davey A, et al,. Cytomegalovirus Associated Hemophagocytic Syndrome in a Child with Crohn's Disease on Azathioprine. J Pediatr Gastroenterol Nutr 2004; 39: 418-21.
8. Vos AC, Bakkal N, Minnee RC, et al,. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflamm Bowel Dis 2011; 17: 1837-45.
9. Magro F, Santos-Antunes J, Albuquerque A, et al,. Epstein-barr virus in inflammatory bowel disease- correlation with different therapeutic regimens. Inflamm Bowel Dis 2013 July; 19: 1710-6.
10. Fries W, Cottone M, Cascio A,. Systematic review: macrophage activation syndrome in inflammatory bowel disease. Aliment Pharmacol Ther 2013; 37: 1033-45.
11. Cohen JI,. Epstein-Barr Virus Infection. N Engl J Med 2000; 343: 481-92.
12. Luzuriaga K, Sullivan J,. Infectious Mononucleosis. N Engl J Med 2010; 362: 1993-2000.
13. Takeuchi K, Tanaka-Taya K, Kazuyama Y, et al,. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol Int 2006; 56: 112-6.
14. Crawford DH, Macsween KF, Higgins CD, et al,. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis 2006; 43: 276-83.
15. Henter JI, Horne A, Arico M, et al,. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31.
16. Afif W, Sandborn WJ, Faubion WA, et al,. Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2013; 19: 1384-9.
17. Beaugerie L, Brousse N, Bouvier AM, et al,. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-25.